Sentences with phrase «officer at cancer»
Dr Emma Smith, senior science communications officer at Cancer Research UK, said: «Revealing the molecule's detailed shape could be the first step towards designing more precise drugs to block it.
https://www.sciencedaily.com/ Not exact matches
Dr. José Baselga, chief medical officer and physician - in - chief at Memorial Sloan Kettering Cancer Center in New York, says it's organizations such as the Kamen Brain Tumor Foundation that will be instrumental in driving the cure.
- Dr. José Baselga, chief medical officer and physician - in - chief at Memorial Sloan Kettering Cancer Center
Prior to joining Oberon, David was Chief Financial Officer and Treasurer at VolitionRx (NYSE MKT: VNRX), a multi-national medical diagnostics company developing simple blood - based tests to accurately diagnose a range of cancers.
«We like to think of Lucas as our Chief Inspiration Officer and know that not only are we inspiring a new generation of cooks and consumers, but we are supporting his efforts to raise funds to serve pediatric cancer patients and their families via restaurants and chef - designed meal kits for cooking at home.»
Not anywhere,» said Maureen Killackey, chief medical officer of the American Cancer Society of New York and New Jersey, and medical director at Memorial Sloan Kettering Cancer Center.
Just weeks after he was named chief medical officer at the Roswell Park Cancer Institute, Dr. Boris Kuvshinoff was diagnosed with an inoperable late - stage tumor in the nasal cavity above his mouth and became a patient there.
«Cancer research is a high priority for both countries — just witness the launch of a new National Cancer Moonshot initiative in the United States early this year,» said Tom Wang, chief international officer at AAAS and director of the AAAS center, referring to the plan President Barack Obama unveiled earlier this year to direct $ 1 billion toward battling cCancer research is a high priority for both countries — just witness the launch of a new National Cancer Moonshot initiative in the United States early this year,» said Tom Wang, chief international officer at AAAS and director of the AAAS center, referring to the plan President Barack Obama unveiled earlier this year to direct $ 1 billion toward battling cCancer Moonshot initiative in the United States early this year,» said Tom Wang, chief international officer at AAAS and director of the AAAS center, referring to the plan President Barack Obama unveiled earlier this year to direct $ 1 billion toward battling cancercancer.
Tops, an M.D. - trained deputy medical examiner at the Armed Forces Institute of Pathology (AFIP) in Washington, D.C., and Dorkina Myrick, an M.D. / Ph.D. physician - scientist, pathologist, and medical officer with the National Cancer Institute (NCI) in nearby Bethesda, Maryland, entered pathology from different directions.
«We desperately need better breast cancer screening tools,» says Otis Webb Brawley, chief medical officer at the American Cancer Socancer screening tools,» says Otis Webb Brawley, chief medical officer at the American Cancer SoCancer Society.
«This study demonstrates the value of using the SEER database to analyze factors associated with surgery as a treatment for localized pancreatic cancer in a large number of patients over a prolonged period of time,» says Dr. Kim, who is also Chief Medical Officer of UH Seidman Cancer Center and the Charles Hubay Professor at Case Western Reserve School of Medcancer in a large number of patients over a prolonged period of time,» says Dr. Kim, who is also Chief Medical Officer of UH Seidman Cancer Center and the Charles Hubay Professor at Case Western Reserve School of MedCancer Center and the Charles Hubay Professor at Case Western Reserve School of Medicine.
«Our analysis found that the lowest satisfaction scores were obtained from population - dense regions of Washington, DC; New York State, California, Maryland and New Jersey, and the best scores were from Louisiana, South Dakota, Iowa, Maine and Vermont,» said senior author Randall Holcombe, MD, Professor, Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, and Chief Medical Officer for Cancer for The Mount Sinai Health System.
It showed effectiveness against liver cancer in a phase II clinical trial and will move into a phase III trial later this year, David Kirn, an oncologist and the company's president and chief executive officer, said at a recent meeting of the American Society for Gene & Cell Therapy in Washington, D.C..
Dr Matthew Lam, Senior Research Officer at Breakthrough Breast Cancer, said: «The conclusions that the researchers have drawn, whilst just hypotheses at this stage, are certainly interesting.
The findings of the randomized study (S6 - 03) were presented at the 2014 San Antonio Breast Cancer Symposium, held Dec. 6 - 9, by Dr. Kerin Adelson, assistant professor of medical oncology at Yale Cancer Center and chief quality officer at Smilow Cancer Hospital at Yale - New Haven.
These studies estimate mammography decreases the number of deaths by anywhere from 35 percent to 0 percent, says Otis Brawley, chief medical officer at the American Cancer Society.
The quest for cancer blood tests — known as liquid biopsies — is one of the hottest areas in oncology, notes Otis Brawley, chief medical and scientific officer at the American Cancer Society, but there's a long way to go: «The tests reported so far have really terrible specificity.&cancer blood tests — known as liquid biopsies — is one of the hottest areas in oncology, notes Otis Brawley, chief medical and scientific officer at the American Cancer Society, but there's a long way to go: «The tests reported so far have really terrible specificity.&Cancer Society, but there's a long way to go: «The tests reported so far have really terrible specificity.»
«The dBET1 and the dFKBP12 compounds are presently in a late stage of lead optimization for therapeutic development in both cancer and non-malignant diseases,» says Prem Das, PhD, chief research business development officer at Dana - Farber.
«Enthusiasm can be the difference between two superb applications,» discloses T. J. Koerner, a scientific program director who, along with other officers and directors, coordinates all review activities at the American Cancer Society.
«This study demonstrates that Prosigna can reliably identify early stage breast cancer patients who have a low risk - of disease recurrence at 10 years, including a substantial proportion of patients with node - positive disease for whom the risk / benefit derived for adjuvant chemotherapy would be at best neutral,» said Dr. Alessandra Cesano, chief medical officer of NanoString Technologies.
Dr. Howard Kaufman, associate director of clinical science and chief surgical officer at Rutgers Cancer Institute of New Jersey, recently told Woodbridge Patch that the state's rising rate of melanoma can be attributed to lengthy sun exposure and lack of adequate safeguards at the Jersey Shore.
Most recently Dr C. Glenn Begley was Chief Scientific Officer at Akriveia Therapeutics, a Californian biotech company focused on discovering and developing the next generation of cancer immunotherapies.
In a keynote address during the National Comprehensive Cancer Network (NCCN) Annual Conference, held March 22 — 24 in Orlando, Florida, Ron Kline, MD, FAAP, medical officer in the patient care models group at the Innovation Center, discussed the pilot Oncology Care Model (OCM), which he directs.
Although Greg Klawitter underwent surgery for lung cancer at the University of Chicago Medicine thirteen years ago, the retired Chicago police officer hasn't forgotten the thoracic surgeon who saved his life.
Rather, we are suggesting a switch in focus from senescent cells to SAMs» said Andrei Gudkov, Ph.D., DSci, Chief Scientific Officer of Everon Biosciences and Chair of Cell Stress Biology at the Roswell Park Cancer Institute.
Based on our findings, the occurrence of cancer is much higher in adults over 75 years of age compared with the proportion of patients in this age group who enroll in clinical trials,» said lead study author Bindu Kanapuru, MD, medical officer in the Division of Hematology Products, Office of Hematology and Oncology Products in the US Food and Drug Administration's (FDA) Center for Drug Evaluation and Research, who presented the results at the 59th American Society of Hematology (ASH) Annual Meeting and Exposition, held December 9 — 12 in Atlanta.
During the TASSA 2016 Conference, Aziz Sancar, MD, PhD, the Sarah Graham Kenan Professor of Biochemistry and Biophysics at the UNC School of Medicine, member of the UNC Lineberger Comprehensive Cancer Center, and Dr. Kenan Sahin, founder and Chief Executive Officer of TIAX LLC, will be joining us as keynote speakers.
Gosselies, Belgium — February 10, 2017 — iTeos Therapeutics SA, a Belgian privately - held biotechnology company applying its expertise in translational tumor immunology to the development of novel cancer immunotherapies, today announced that Michel Detheux, iTeos» Chief Executive Officer, will present at the 2017 BIO CEO & Investor Conference on Tuesday, February 14 2017 at 10:45 a.m. ET in Park North at The Waldorf Astoria in New York, NY.
A program officer with the Physical Sciences in Oncology program at the National Cancer Institute learned about the results and encouraged Fredberg to do a similar analysis using cancer Cancer Institute learned about the results and encouraged Fredberg to do a similar analysis using cancer cancer cells.
Its membership is defined as the Associate Deans of Research from the Colleges, the Director of the Hollings Cancer Center, the Chief Research Informatics Officer, the Director of the South Carolina Clinical and Translational Research Institute, the Assistant Provost for Research Infrastructure, the Assistant Provost for Research Compliance and Regulatory Affairs, and two at - large members.
WCTC 1450 AM — «Jersey Central» with host Bert Baron — May 2, 2017 Rutgers Cancer Institute of New Jersey Chief Medical Officer Dr. Deborah Toppmeyer and genetic counselor Hetal Vig, who are both part of the Stacy Goldstein Breast Cancer Center and LIFE Center at the Institute, discuss the topic of hereditary cancers.
Those experts also called for insurance coverage, via Medicare and perhaps private insurers, of genomic testing of tumors, said Barrett J. Rollins, chief scientific officer at the Dana - Farber Cancer Institute in Boston, who attended the meeting.
New Jersey 101.5 FM Radio — October 1, 2012 CINJ Chief Medical Officer Deborah L. Toppmeyer, MD, director of CINJ's Stacy Goldstein Breast Cancer Center and LIFE Center at CINJ, and associate professor of medicine at UMDNJ - Robert Wood Johnson Medical School, describes the importance of mammograms
To create the Hub, the researchers — led by Broad chief scientific officer Todd Golub and postdoctoral scholar Steven Corsello, an oncologist at Dana - Farber Cancer Institute — scoured public and proprietary databases to identify compounds representing a diverse range of targets and chemical structures.
«Enabling and empowering global experts to drive disruptive innovation is central to our mission at CRI,» said Aiman Shalabi, Pharm.D., MBA, Cancer Research Institute Chief Medical Officer.
Gosselies, Belgium — August 8, 2017 — iTeos Therapeutics SA, a biotechnology company developing novel cancer immunotherapies, today announces that Michel Detheux, iTeos» Chief Executive Officer, will present a company overview at the 2017 Wedbush PacGrow Healthcare Conference on Tuesday, August 15, 2017 at 12:45 a.m. ET in New York, NY.
Rutgers Cancer Institute's Chief Nursing Officer Janet Gordils - Perez, DNP, RN, ANP - BC, AOCNP, shares more about what this accreditation means for oncology nurses at the New Brunswick facility and across the state, as well as the ultimate impact it will have on patients.
Rutgers Cancer Institute of New Jersey Chief Surgical Officer H. Richard Alexander, Jr., MD, FACS, professor of surgery at Rutgers Robert Wood Johnson Medical School, shares more about this rare cCancer Institute of New Jersey Chief Surgical Officer H. Richard Alexander, Jr., MD, FACS, professor of surgery at Rutgers Robert Wood Johnson Medical School, shares more about this rare cancercancer.
«If the pilot trial is successful, we plan to pursue a larger trial to explore this strategy's potential as a straightforward and cost - effective way to improve the existing therapy for AML and MDS,» said Peter Jones, Ph.D., D.Sc., co-senior author of the PNAS study, chief scientific officer at Van Andel Research Institute (VARI) and co-leader of the Van Andel Research Institute — Stand Up To Cancer (VARI — SU2C) Epigenetics Dream Team.
And Dr. Len Lichtenfeld, deputy chief medical officer for the American Cancer Society, noted that this was an observational study that only looked at the experience of one institution.
Otis W. Brawley, MD, the chief medical officer at the American Cancer Society, echoed these thoughts in an editorial accompanying the study.
«There's an overdiagnosis of thyroid cancer going on, and it's a real mess,» says Otis Brawley, MD, chief medical officer at the American Cancer Socancer going on, and it's a real mess,» says Otis Brawley, MD, chief medical officer at the American Cancer SoCancer Society.
In fact, a 62 - year - old man from Singapore who was taking the drug was detained at airport customs for four hours before US immigration officers «were satisfied that he was not a security threat,» Dr. Eng - Huat Tan of the National Cancer Centre in Singapore and his colleagues report in a case study published in the Annals of Oncology.
TMAO is a «greater risk for inflammation and all things that go along with inflammation like stroke, memory loss, impotence, decaying orgasm quality, wrinkling, cancer, and brain rot,» says Dr. Michael Rozin, MD, chief wellness officer and chairman of the Wellness Institute at the Cleveland Clinic.
Take Howard Simkevitz, general counsel and chief privacy officer at the Ontario Institute For Cancer Research.
United States About Blog Dr. Lichtenfeld currently serves as Deputy Chief Medical Officer for the American Cancer Society in the Society's Office of the Chief Medical Officer located at the Society's Corporate Center in Atlanta.
AHCSA Maternal Health Tackling Smoking Project Officer Mary - Anne Williams said the programs feature everyday stories and resources about cancer, and resonate strongly for staff at the organisation after AHCSA lost its widely respected, long - standing CEO Mary Buckskin to cancer last year, aged just 57.